Log In
BCIQ
Print this Print this
 

ANAVEX 3-71 (formerly AF710B)

  Manage Alerts
Collapse Summary General Information
Company Anavex Life Sciences Corp.
DescriptionSigma-1 receptor and muscarinic acetylcholine receptor M1 (CHRM1; HM1) activator
Molecular Target Sigma-1 receptor ; Muscarinic acetylcholine receptor M1 (CHRM1) (HM1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/07/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today